JPRN-UMIN000041915
Completed
N/A
Identification of biomarkers that predict responsiveness to Dupilumab among severe asthma - Biomarker for Dupilumab
ational Hospital Organization Tokyo National Hospital0 sites15 target enrollmentSeptember 28, 2020
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ational Hospital Organization Tokyo National Hospital
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patient whom the researchers think is not suitable for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
Identifying factors that help predict improvement with deep brain stimulation (a surgical treatment) for obsessive-compulsive disorderHealth Condition 1: F422- Mixed obsessional thoughts and actsCTRI/2020/03/024131Wellcome Trust DBT India Alliance
Active, Not Recruiting
Phase 1
prediction of response to therapy in inflammatory bowel diseaseEUCTR2018-002925-47-ESFundación de Investigación Biomédica del Hospital Universitario de La Princesa180
Recruiting
N/A
Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancerunresectable or recurrent non-small cell lung cancerJPRN-UMIN000026040Kagoshima University90
Completed
N/A
Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung canceron-small-cell lung cancerJPRN-UMIN000022505Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
Recruiting
N/A
Development of biomarker predicting the response of immunotherapy for patients with urothelial cancer using urine miRNAurothelial cancerJPRN-UMIN000047198Tokyo Medical University120